Philip Gotwals is Head, Search and Evaluation, Business Development and Licensing, at Novartis Institutes for BioMedical Research. Previously, he was Executive Director, Exploratory Immuno-Oncology, and instrumental in building NIBR’s immuno-oncology strategic research area. Dr. Gotwals has more than 20 years of experience in the biotechnology and pharmaceutical industries, leading internal and collaborative R&D programs from drug discovery to new drug application filing and leading the licensing of product candidates. Prior to joining Novartis, Phil was on the management team at Altus Pharmaceuticals, where he was responsible for all product development project management. Prior to his engagement at Altus, he was senior director of program and alliance management at Biogen, where he oversaw leadership of internal and allied early product development teams in the autoimmune, neurology, and oncology therapeutic areas.
Phil holds a Ph.D. in genetics from the University of California at Berkeley, performed postdoctoral research at MIT, and completed the Program for Management Development at Harvard Business School.